New guidance on 'artificial pancreas' technology for pregnant women with type 1 diabetes
NICE has released draft guidance recommending that pregnant women with type 1 diabetes be offered 'artificial pancreas' technology, known as hybrid closed loop systems. This technology automates insulin delivery to improve health outcomes for both mother and baby.
Why it matters
This recommendation could significantly reduce pregnancy complications for thousands of women by providing more precise blood sugar management.
Women with type 1 diabetes who are pregnant or planning a pregnancy should be offered a pregnancy-specific 'artificial pancreas' device. That is the recommendation in draft guidance published today by NICE.
The report is a straightforward summary of medical guidance and clinical recommendations without ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in